Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens
- 1 September 1995
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 284 (3) , 241-247
- https://doi.org/10.1016/0014-2999(95)00318-f
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorPublished by Wiley ,2001
- 1-Alkyl-3-(1-naphthoyl)pyrroles: A new class of cannabinoidTetrahedron Letters, 1995
- Design, Synthesis and Pharmacology of Cannabimimetic IndolesBioorganic & Medicinal Chemistry Letters, 1994
- Cross‐tolerance between delta‐9‐tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212‐2 and anandamideBritish Journal of Pharmacology, 1993
- The evidence for the existence of cannabinoid receptorsGeneral Pharmacology: The Vascular System, 1993
- Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea‐pig small intestineBritish Journal of Pharmacology, 1992
- pA2 and receptor differentiation: A statistical analysis of competitive antagonismLife Sciences, 1979
- Isolation, Structure, and Partial Synthesis of an Active Constituent of HashishJournal of the American Chemical Society, 1964